APA (7th ed.) Citation

Chang, Y., Chen, Y., Yang, C., Ho, H., Yang, J. F., Chou, Y., . . . Yang, P. (2025). Pharmacokinetics and Safety Profile of SNS812, a First in Human Fully Modified siRNA Targeting Wide‐Spectrum SARS‐CoV‐2, in Healthy Subjects. CTS: Clinical & Translational Science, 18(3), 1. https://doi.org/10.1111/cts.70202

Chicago Style (17th ed.) Citation

Chang, Yi‐Chung, Yi‐Fen Chen, Chi‐Fan Yang, Hui‐Ju Ho, Jen Fu Yang, Yuan‐Lin Chou, Ching‐Wen Lin, and Pan‐Chyr Yang. "Pharmacokinetics and Safety Profile of SNS812, a First in Human Fully Modified SiRNA Targeting Wide‐Spectrum SARS‐CoV‐2, in Healthy Subjects." CTS: Clinical & Translational Science 18, no. 3 (2025): 1. https://doi.org/10.1111/cts.70202.

MLA (9th ed.) Citation

Chang, Yi‐Chung, et al. "Pharmacokinetics and Safety Profile of SNS812, a First in Human Fully Modified SiRNA Targeting Wide‐Spectrum SARS‐CoV‐2, in Healthy Subjects." CTS: Clinical & Translational Science, vol. 18, no. 3, 2025, p. 1, https://doi.org/10.1111/cts.70202.